查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999285

神經科病患監測市場：按產品類型、監護模式、組件、連接方式、技術、部署方法、應用和最終用戶分類－2026-2032年全球市場預測

Neurology Patient Monitoring Market by Product Type, Monitoring Mode, Component, Connectivity, Technology, Deployment Mode, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年神經病學領域的病患監測市場價值為 60 億美元，預計到 2026 年將成長至 65 億美元，複合年成長率為 9.70%，到 2032 年將達到 114.9 億美元。

主要市場統計數據
基準年 2025 60億美元
預計年份：2026年 65億美元
預測年份 2032 114.9億美元
複合年成長率 (%) 9.70%

對神經科病患監測領域進行全面概述，揭示臨床因素、技術融合以及相關人員的關鍵決策因素。

在臨床需求、技術創新和醫療服務模式轉移的交會下，神經病學病患監測領域正迅速發展。本文闡述了推動投資和應用的關鍵臨床需求，包括持續、準確的神經系統數據對於改善急慢性疾病治療效果的重要性，並解釋了這一領域的發展背景。此外，本文還說明了感測技術、訊號處理和軟體分析的整合如何重新定義即時監護對臨床醫生和看護者的價值。

感測技術、人工智慧驅動的分析以及混合護理模式的快速發展如何重塑神經監測領域的臨床工作流程、監管預期和競爭優勢。

神經病學領域的病患監測市場正經歷著變革性的轉變，這些變革正在加速臨床應用，並重塑市場競爭動態。感測器精度和訊號採集技術的進步帶來了前所未有的洞察。同時，邊緣處理和雲端分析技術能夠加快資料解讀速度，並發出可操作的警報。此外，人工智慧在數據解讀過程中的應用，透過檢測異常情況、確定病例優先順序和縮短干預時間，顯著提升了臨床醫生的工作流程。因此，價值的焦點正從原始資料收集轉向智慧化的、情境化的決策支援。

本研究探討了 2025 年關稅政策的變化將如何促使供應鏈重組、採購多元化以及策略採購政策的轉變，進而影響神經監測操作。

美國2025年實施的關稅可能會引發神經系統疾病病患監測生態系統內一系列運作和策略調整。進口零件和成品的成本波動將影響籌資策略，促使供應商重新評估其供應鏈佈局，並探索近岸外包和替代採購方案。隨著各機構的調整，採購週期和供應商談判可能會延長，從而影響醫療機構設備的可用性和部署速度。

多層分割分析，闡明產品模式、監測模式、臨床應用、最終用戶環境、組件、部署選項、連接方式以及推動部署的技術方向。

精準的市場區隔觀點揭示了創新和應用集中的領域，以及仍存在未滿足需求的領域。就產品類型而言，腦電圖 (EEG)、肌電圖 (EMG)、顱內壓監測系統和經顱都卜勒設備各自擁有獨特的臨床應用場景、檢驗流程和整合要求，供應商需要根據急性神經重症監護和長期門診評估的不同需求來調整其價值提案。從監測模式的角度來看，諸如皮層腦電圖和顱內壓監測等侵入性解決方案可為重症監護中的決策提供高度精確的訊號。另一方面，包括腦電圖、肌電圖和經顱都卜勒在內的無創技術適用於包括門診、睡眠和神經科科診所在內的多種環境，從而形成了互補的應用曲線，並對臨床醫生培訓和監管核准提出了不同的要求。

醫療保健系統、法規結構和數位化準備的區域差異如何影響世界各地的優先事項、商業化和在地化策略？

區域趨勢正在形成差異化的需求訊號和法規環境，進而影響產品策略、夥伴關係和商業化計畫。在美洲，臨床應用通常與綜合醫療保健系統和大學醫院密切相關，這些機構優先考慮用於重症監護和研究的先進監測技術；與此同時，在以價值為基礎的醫療和遠端病患管理措施的推動下，人們對家庭監測的興趣也迅速成長。在歐洲、中東和非洲，報銷體系和醫療基礎設施的差異造成了臨床需求和成本控制要求必須兼顧的複雜局面，因此，制定個人化的證據建構和分發策略對於應對當地的監管流程至關重要。

深入了解產品歷史、軟體差異化、策略夥伴關係和售後支援如何決定神經監測領域的競爭優勢和採用軌跡。

神經系統疾病病患監測領域的競爭動態是由傳統醫療設備專業知識、新興軟體能力以及連接臨床、技術和服務能力的策略聯盟共同塑造的。成熟的醫療設備製造商擁有豐富的臨床檢驗經驗和分銷網路，能夠促進醫院層面的部署；而新參與企業和科技公司則透過軟體主導的產品、人工智慧和以用戶為中心的設計脫穎而出。醫療設備製造商、臨床研究機構和雲端平台供應商之間的夥伴關係能夠快速產生證據並實現可擴展的部署，從而創造出一種合作模式優於純粹內部成長策略的環境。

為領導者提供實用指導，以協調產品模組化、臨床檢驗、部署柔軟性和強大的採購系統，從而確保長期部署和營運彈性。

產業領導者應採取協調一致的策略，將產品開發、法規遵循規劃和商業性執行有機結合，以確保臨床相關性和營運永續性。優先考慮模組化產品架構，實現組件重複使用和快速迭代，從而降低供應鏈中斷和關稅相關成本壓力。同時，投資強大的資料管治、網路安全和臨床檢驗項目，以支援人工智慧驅動的功能，並確保可解釋性和臨床醫生的信任。這些投資有助於跨司法管轄區的解決方案認證，並滿足醫院的IT和合規要求。

我們以證據為基礎的調查方法，結合了直接的臨床相關人員、間接的技術審查和結構化的分析方法，為決策者提供了可操作的見解。

本研究整合了對臨床醫生、醫療系統採購經理和產品主管的定性研究，並輔以對監管申報文件、臨床文獻和公開技術文件的二次分析，旨在全面了解神經病學領域的病患監測技術及其應用趨勢。研究整合了主要資訊來源，以提取有關工作流程整合、臨床優先事項和採購決策標準的經驗性見解；同時，研究也整合了二級資訊來源，以提供技術背景，並對設備功能和監管考慮進行三角檢驗。

我們透過簡潔地整合策略挑戰，將創新轉化為臨床影響，這些策略挑戰優先考慮互通性、證據生成、穩健實施和以臨床醫生為中心的設計。

總之，神經病學領域的病患監測正處於轉折點，其驅動力包括技術的成熟、醫療服務模式的演進以及供應鏈趨勢的轉變。能夠整合高精度感測、可解釋分析和靈活部署方案的機構，將更有能力滿足醫院、門診中心和居家照護機構的多樣化需求。同樣重要的是，這些機構還需具備克服監管複雜性、透過真實世界數據展現臨床價值以及在政策和經濟逆風中保持穩健的供應鏈和生產策略的能力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：神經病學病患監測市場：依產品類型分類

  • 腦電圖（EEG）
  • 肌電圖（EMG）
  • ICP監測系統
  • TCD設備

第9章：神經病學領域的病患監測市場－依監護方法分類

  • 侵入性
    • 腦電皮層圖
    • ICP監測
  • 非侵入性
    • 腦電圖（EEG）
    • EMG
    • TCD

第10章：神經病學病患監測市場：依組件分類

  • 硬體
  • 服務
  • 軟體

第11章 神經病學病患監測市場：連結性

  • 有線
  • 無線的

第12章 神經病學病患監測市場：依技術分類

  • 人工智慧
  • 傳統的

第13章：神經病學病患監測市場：依部署模式分類

  • 基於雲端的
  • 現場

第14章 神經病學病患監測市場：依應用領域分類

  • 癲癇監測
  • 神經退化性疾病監測
  • 睡眠障礙監測
  • 中風監測

第15章：神經病學病患監測市場：依最終用戶分類

  • 門診部
  • 居家照護設施
  • 醫院

第16章 神經科病患監測市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第17章 神經病學病患監測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第18章 神經病學病患監測市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第19章：美國神經病學領域的病患監測市場

第20章：中國神經病學領域的病患監測市場

第21章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advanced Brain Monitoring, Inc.
  • BioSerenity SAS
  • BrainScope Company, Inc.
  • Cadwell Industries, Inc.
  • Compumedics Limited
  • Dragerwerk AG & Co. KGaA
  • Electrical Geodesics, Inc.（EGI）
  • Gaeltec Devices Limited
  • GE HealthCare
  • Integra LifeSciences Holdings Corporation
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medtronic plc
  • Natus Medical Incorporated
  • Neural Analytics, Inc.
  • NeuroSky, Inc.
  • Neurosoft Ltd.
  • NeuroWave Systems, Inc.
  • Nihon Kohden Corporation
  • Nonin Medical, Inc.
  • Raumedic AG
  • Rimed Ltd.
  • Siemens Healthcare GmbH
  • Sophysa SAS
  • Spiegelberg GmbH & Co. KG
Product Code: MRR-3A2E844FCDB5

The Neurology Patient Monitoring Market was valued at USD 6.00 billion in 2025 and is projected to grow to USD 6.50 billion in 2026, with a CAGR of 9.70%, reaching USD 11.49 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.00 billion
Estimated Year [2026] USD 6.50 billion
Forecast Year [2032] USD 11.49 billion
CAGR (%) 9.70%

A comprehensive orientation to the neurology patient monitoring landscape that clarifies clinical drivers, technological convergence, and critical decision levers for stakeholders

The neurology patient monitoring domain is undergoing rapid evolution as clinical demand intersects with technological innovation and shifting care delivery paradigms. This introduction sets the stage by clarifying the clinical imperatives driving investment and adoption, including the need for continuous, accurate neurological data to improve outcomes across acute and chronic conditions. It also outlines how convergence among sensing technologies, signal processing, and software-enabled analytics is redefining what real-time monitoring can deliver for clinicians and caregivers.

Against this backdrop, stakeholders must understand the interplay of device modalities, monitoring modes, and care environments that shape procurement and deployment decisions. The landscape is influenced by hospital infrastructure, the maturation of home and ambulatory care models, regulatory scrutiny of data integrity and cybersecurity, and growing expectations for interoperability. By framing these forces early, readers gain a practical foundation for evaluating technologies, partnerships, and capabilities that will determine competitive differentiation and clinical value in the coming years.

How rapid advances in sensing, AI-driven analytics, and hybrid care models are reshaping clinical workflows, regulatory expectations, and competitive moats in neurology monitoring

The neurology patient monitoring space is experiencing transformative shifts that are accelerating clinical adoption and redefining competitive dynamics. Advancements in sensor fidelity and signal acquisition are enabling previously unobtainable insights, while edge processing and cloud-enabled analytics allow for faster interpretation and actionable alerts. Simultaneously, the integration of artificial intelligence into interpretation pipelines is augmenting clinician workflows by flagging anomalies, prioritizing cases, and reducing time to intervention, thus shifting the locus of value from raw data capture to intelligent, context-aware decision support.

In addition to technological progress, care-delivery models are shifting away from exclusive reliance on inpatient monitoring toward hybridized approaches that blend ambulatory, home-based, and hospital settings. This transition requires more robust connectivity architectures, flexible deployment options, and an emphasis on patient-centric device ergonomics. Regulatory frameworks are also evolving to address software as a medical device, data privacy, and post-market surveillance, which in turn influences product design, validation strategies, and commercialization pathways. Consequently, organizations that align product innovation with clinical workflows, regulatory foresight, and scalable support models will capture greater clinical relevance and operational traction as these transformative forces converge.

Examining how tariff policy changes in 2025 can prompt supply chain reconfiguration, sourcing diversification, and strategic procurement shifts affecting neurology monitoring operations

The introduction of United States tariffs in 2025 has potential to create a cascade of operational and strategic adjustments across the neurology patient monitoring ecosystem. Tariff-driven cost changes for imported components and finished devices can influence procurement strategies, prompting suppliers to reassess supply chain footprints and to explore near-shoring or alternative sourcing. As organizations adapt, procurement timelines and vendor negotiations may extend, which could affect device availability and the pacing of deployments in clinical settings.

Beyond immediate cost implications, tariffs can catalyze broader supplier rationalization and design-for-manufacturability efforts that emphasize component standardization and modular architectures. These responses may spur greater collaboration between device manufacturers and contract manufacturers to localize production or redesign products to reduce tariff exposure. At the same time, providers and health systems might prioritize vendors with resilient supply chains and clear mitigation plans, thereby reshaping vendor selection criteria. Over the medium term, the cumulative effects of tariff policy will be mediated by corporate responses, currency movements, and the evolving balance between cost pressures and the clinical imperative to maintain uninterrupted neurologic monitoring capabilities.

A layered segmentation analysis that deciphers product modalities, monitoring modes, clinical applications, end-use environments, components, deployment options, connectivity, and technology vectors driving adoption

A nuanced segmentation lens illuminates where innovation and adoption are concentrated and where unmet needs persist. When considering product categories, electroencephalography (EEG), electromyography (EMG), intracranial pressure monitoring systems, and transcranial Doppler devices each carry distinct clinical use cases, validation pathways, and integration requirements, and vendors must tailor value propositions to the differential needs of acute neuro-critical care versus longitudinal ambulatory assessment. In terms of monitoring mode, invasive solutions such as electrocorticography and intracranial pressure monitoring offer high-fidelity signals for critical care decision making, while non invasive techniques including EEG, EMG, and transcranial Doppler provide broader applicability across outpatient, sleep, and neurology clinic contexts, creating complementary adoption curves and differing requirements for clinician training and regulatory clearance.

Application-focused segmentation further refines opportunity areas, with epilepsy monitoring demanding high temporal resolution and artifact rejection; neurodegenerative disease monitoring emphasizing longitudinal data capture and patient comfort; sleep disorder monitoring requiring home-friendly, minimally obtrusive designs; and stroke monitoring prioritizing rapid detection and integration with acute care pathways. End-user distinctions reveal distinct procurement cycles and support needs across ambulatory care centers, home care settings, and hospitals, each of which imposes specific constraints related to staffing, infrastructure, and reimbursement. Component segmentation separates hardware, services, and software revenue streams and underscores the rising importance of software-driven analytics and post-sale clinical support. Deployment mode differences between cloud-based and on-premise solutions shape data governance, latency, and scale considerations, while connectivity choices between wired and wireless determine installation complexity, mobility, and patient experience. Finally, technology differentiation between AI-enabled systems and traditional approaches highlights divergent development priorities: AI-enabled offerings require robust training datasets, explainability, and post-market performance monitoring, whereas traditional systems focus on deterministic algorithms and certified signal processing pipelines. Taken together, these segmentation perspectives enable a layered understanding of where clinical value is realized, how adoption barriers vary, and where strategic investments will yield the greatest returns.

How geographic differences in healthcare systems, regulatory frameworks, and digital readiness shape prioritization, commercialization, and localization strategies across global regions

Regional dynamics create differentiated demand signals and regulatory contexts that influence product strategy, partnerships, and commercialization plans. In the Americas, clinical adoption often aligns with integrated health systems and academic medical centers that prioritize advanced monitoring for critical care and research, alongside a rapidly growing interest in home-based monitoring driven by value-based care and remote patient management initiatives. Across Europe, Middle East & Africa, variations in reimbursement frameworks and healthcare infrastructure result in a heterogeneous landscape where clinical needs are balanced against cost containment imperatives, and where local regulatory pathways necessitate tailored evidence generation and distribution strategies.

In the Asia-Pacific region, accelerating investment in healthcare infrastructure, a strong emphasis on domestic manufacturing capability, and rapidly expanding patient populations are creating vigorous demand for scalable, cost-effective monitoring solutions. Each of these regional contexts also differs in digital health readiness, cybersecurity expectations, and clinical workforce capacity, which collectively shape product localization requirements, channel strategies, and service models. Therefore, firms seeking to expand their footprint must align regulatory planning, clinical evidence generation, and operational support with the distinct priorities and constraints present within each geographic region.

Insights into how product heritage, software differentiation, strategic partnerships, and post-sale support determine competitive advantage and adoption trajectories in neurology monitoring

Competitive dynamics in the neurology patient monitoring space are being defined by a combination of legacy device expertise, emergent software capabilities, and strategic alliances that bridge clinical, technological, and services competencies. Established device manufacturers contribute deep clinical validation experience and distribution networks that facilitate hospital-level adoption, while newer entrants and technology firms are differentiating through software-defined offerings, artificial intelligence, and user-centric design. Partnerships between device makers, clinical research entities, and cloud-platform providers are enabling accelerated evidence generation and deployment scalability, creating an environment where collaborative models often outpace purely organic growth strategies.

Moreover, companies that demonstrate clear post-sale clinical support, training programs, and evidence of real-world performance are gaining preferential access to procurement decision makers. Investment in regulatory affairs, quality systems, and cybersecurity governance further distinguishes credible suppliers from less mature players. As a result, competitive advantage accrues to organizations that can effectively combine validated sensing hardware, robust signal processing, and transparent, clinically validated analytics delivered through scalable service frameworks. This multi-dimensional approach to product and market execution is increasingly essential for achieving sustained traction in complex healthcare environments.

Action-oriented guidance for leaders to align product modularity, clinical validation, deployment flexibility, and resilient sourcing to secure long-term adoption and operational resilience

Industry leaders should pursue a coordinated strategy that aligns product development, regulatory planning, and commercial execution to capture clinical relevance and operational sustainability. Prioritize modular product architectures that enable component reuse and rapid iteration, thereby reducing exposure to supply chain disruptions and tariff-driven cost pressures. Simultaneously, invest in robust data governance, cybersecurity, and clinical validation programs that support AI-enabled functionality while ensuring explainability and clinician trust. These investments will make it easier to certify solutions across jurisdictions and to satisfy hospital IT and compliance requirements.

In the commercial realm, cultivate flexible deployment and pricing models that accommodate hospital, ambulatory, and home-based settings; emphasize bundled offerings that integrate hardware, software, and services to simplify procurement and to demonstrate downstream care benefits. Forge strategic clinical partnerships to build longitudinal evidence and to accelerate guideline adoption, and prioritize channels and support infrastructures that can rapidly scale training and technical assistance. Finally, maintain a proactive supply chain and sourcing strategy that includes diversified suppliers, regional manufacturing options where feasible, and design-for-manufacture principles to preserve margin and ensure continuity of care delivery as market conditions evolve.

An evidence-driven methodology combining primary clinical engagement, secondary technical review, and structured analytical approaches to produce actionable intelligence for decision makers

This research integrates primary qualitative engagements with clinicians, health system procurement leaders, and product executives, supplemented by secondary analysis of regulatory filings, clinical literature, and publicly available technical documentation to construct a holistic view of neurology patient monitoring technologies and adoption dynamics. Primary inputs were synthesized to capture experiential insights on workflow integration, clinical priorities, and procurement decision criteria, while secondary sources provided technical context and supported triangulation of device capabilities and regulatory considerations.

Analytical methods included comparative technology assessment, scenario analysis to evaluate the implications of policy and supply chain events, and segmentation mapping to identify unmet needs across product types, monitoring modes, applications, end users, components, deployment models, connectivity options, and technology approaches. Throughout the analysis, emphasis was placed on validation against clinician experience and on the transparency of assumptions related to adoption drivers, regulatory milestones, and operational constraints. The methodology therefore blends practitioner-informed perspectives with structured analytical techniques to provide actionable intelligence for decision makers.

A succinct synthesis of strategic imperatives emphasizing interoperability, evidence generation, resilient operations, and clinician-centered design to translate innovation into clinical impact

In conclusion, the neurology patient monitoring landscape is at an inflection point driven by technological maturation, evolving care delivery models, and shifting supply chain dynamics. Organizations that integrate high-fidelity sensing, explainable analytics, and flexible deployment options will be best positioned to meet the diverse needs of hospitals, ambulatory centers, and home care environments. Equally important is the ability to navigate regulatory complexity, to demonstrate clinical value through real-world evidence, and to maintain resilient supply and manufacturing strategies in the face of policy and economic headwinds.

As stakeholders plan next steps, they should focus on interoperability, clinician-centric design, and post-market performance monitoring to ensure sustained clinical adoption and patient benefit. By aligning product development, evidence generation, and commercial execution, leaders can convert technological promise into measurable clinical impact and durable organizational advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurology Patient Monitoring Market, by Product Type

  • 8.1. EEG
  • 8.2. EMG
  • 8.3. ICP Monitoring System
  • 8.4. TCD Device

9. Neurology Patient Monitoring Market, by Monitoring Mode

  • 9.1. Invasive
    • 9.1.1. Electrocorticography
    • 9.1.2. ICP Monitoring
  • 9.2. Non Invasive
    • 9.2.1. EEG
    • 9.2.2. EMG
    • 9.2.3. TCD

10. Neurology Patient Monitoring Market, by Component

  • 10.1. Hardware
  • 10.2. Services
  • 10.3. Software

11. Neurology Patient Monitoring Market, by Connectivity

  • 11.1. Wired
  • 11.2. Wireless

12. Neurology Patient Monitoring Market, by Technology

  • 12.1. AI Enabled
  • 12.2. Traditional

13. Neurology Patient Monitoring Market, by Deployment Mode

  • 13.1. Cloud Based
  • 13.2. On Premise

14. Neurology Patient Monitoring Market, by Application

  • 14.1. Epilepsy Monitoring
  • 14.2. Neurodegenerative Disease Monitoring
  • 14.3. Sleep Disorder Monitoring
  • 14.4. Stroke Monitoring

15. Neurology Patient Monitoring Market, by End User

  • 15.1. Ambulatory Care Centers
  • 15.2. Home Care Settings
  • 15.3. Hospitals

16. Neurology Patient Monitoring Market, by Region

  • 16.1. Americas
    • 16.1.1. North America
    • 16.1.2. Latin America
  • 16.2. Europe, Middle East & Africa
    • 16.2.1. Europe
    • 16.2.2. Middle East
    • 16.2.3. Africa
  • 16.3. Asia-Pacific

17. Neurology Patient Monitoring Market, by Group

  • 17.1. ASEAN
  • 17.2. GCC
  • 17.3. European Union
  • 17.4. BRICS
  • 17.5. G7
  • 17.6. NATO

18. Neurology Patient Monitoring Market, by Country

  • 18.1. United States
  • 18.2. Canada
  • 18.3. Mexico
  • 18.4. Brazil
  • 18.5. United Kingdom
  • 18.6. Germany
  • 18.7. France
  • 18.8. Russia
  • 18.9. Italy
  • 18.10. Spain
  • 18.11. China
  • 18.12. India
  • 18.13. Japan
  • 18.14. Australia
  • 18.15. South Korea

19. United States Neurology Patient Monitoring Market

20. China Neurology Patient Monitoring Market

21. Competitive Landscape

  • 21.1. Market Concentration Analysis, 2025
    • 21.1.1. Concentration Ratio (CR)
    • 21.1.2. Herfindahl Hirschman Index (HHI)
  • 21.2. Recent Developments & Impact Analysis, 2025
  • 21.3. Product Portfolio Analysis, 2025
  • 21.4. Benchmarking Analysis, 2025
  • 21.5. Advanced Brain Monitoring, Inc.
  • 21.6. BioSerenity SAS
  • 21.7. BrainScope Company, Inc.
  • 21.8. Cadwell Industries, Inc.
  • 21.9. Compumedics Limited
  • 21.10. Dragerwerk AG & Co. KGaA
  • 21.11. Electrical Geodesics, Inc. (EGI)
  • 21.12. Gaeltec Devices Limited
  • 21.13. GE HealthCare
  • 21.14. Integra LifeSciences Holdings Corporation
  • 21.15. Koninklijke Philips N.V.
  • 21.16. Masimo Corporation
  • 21.17. Medtronic plc
  • 21.18. Natus Medical Incorporated
  • 21.19. Neural Analytics, Inc.
  • 21.20. NeuroSky, Inc.
  • 21.21. Neurosoft Ltd.
  • 21.22. NeuroWave Systems, Inc.
  • 21.23. Nihon Kohden Corporation
  • 21.24. Nonin Medical, Inc.
  • 21.25. Raumedic AG
  • 21.26. Rimed Ltd.
  • 21.27. Siemens Healthcare GmbH
  • 21.28. Sophysa S.A.S.
  • 21.29. Spiegelberg GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 15. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 16. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 197. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 198. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 200. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 201. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 230. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 231. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 233. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 234. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 241. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 242. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 244. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)